Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAIN-TVT
NCT07429019Not yet recruiting
- Sponsor
- Hadassah Medical Organization
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in postoperative pain comparing Bupivacaine surgical site injection with Placebo: Saline Injection (2 arms). Primary endpoint: Numerical Rating Scale for Pain at 6 months. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07429019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07429019.